Literature DB >> 21936732

Role of cytokines in atypical depression.

Ho-Kyoung Yoon1, Yong-Ku Kim, Heon-Jeong Lee, Do-Young Kwon, Leen Kim.   

Abstract

BACKGROUND: Atypical depression (AD) is considered a biologically and psychologically distinct subtype of depression. AD, contrary to melancholic depression (MD), may have different alteration in cytokine activity. AIMS: We aimed to investigate the differences of cytokine activity between AD patients and MD patients. Among psychiatric patients visited to the Psychiatry Department, Korea University Medical Center, 105 patients with major depression who met the Diagnostic and Statistical Manual (DSM-IV) criteria based on clinical interviews using a Structured Clinical Interview for DSM-IV were recruited. Among 105 patients, 35 patients had atypical feature. We measured in vitro cytokines (interleukins) IL-2, IL-4, IL-6 and tumor necrosis factor-α (TNF-α).
RESULTS: Decreased IL-4 and increased IL-2 was observed in AD patients. IL-6 and TNF-α level of AD patients showed no difference from the controls.
CONCLUSIONS: Contrary to MD, AD has reversed vegetative symptoms, i.e. hypersomnia and hyperphagia. It is assumed that the phenotype difference between AD and MD might be related to Th1 cytokines (IL-2) and Th2 cytokines (IL-4) and not related to monocytic cytokines (IL-6, and TNF-α).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21936732     DOI: 10.3109/08039488.2011.611894

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  17 in total

Review 1.  The brain-adipocyte-gut network: Linking obesity and depression subtypes.

Authors:  Carla M Patist; Nicolas J C Stapelberg; Eugene F Du Toit; John P Headrick
Journal:  Cogn Affect Behav Neurosci       Date:  2018-12       Impact factor: 3.282

2.  Prospective associations of depression subtypes with cardio-metabolic risk factors in the general population.

Authors:  A M Lasserre; M-P F Strippoli; J Glaus; M Gholam-Rezaee; C L Vandeleur; E Castelao; P Marques-Vidal; G Waeber; P Vollenweider; M Preisig
Journal:  Mol Psychiatry       Date:  2016-10-11       Impact factor: 15.992

3.  Inflammation and depression in young people: a systematic review and proposed inflammatory pathways.

Authors:  Yara J Toenders; Liliana Laskaris; Christopher G Davey; Michael Berk; Yuri Milaneschi; Femke Lamers; Brenda W J H Penninx; Lianne Schmaal
Journal:  Mol Psychiatry       Date:  2021-10-11       Impact factor: 15.992

4.  Association between major depression and cardiovascular risk: the role of antidepressant medication.

Authors:  Linn K Kuehl; Christoph Muhtz; Kim Hinkelmann; Lucia Dettenborn; Katja Wingenfeld; Carsten Spitzer; Christian Otte
Journal:  Psychopharmacology (Berl)       Date:  2016-07-27       Impact factor: 4.530

Review 5.  Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression.

Authors:  Eunsoo Won; Yong-Ku Kim
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 6.  The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments.

Authors:  Beatrice Bortolato; Andre F Carvalho; Joanna K Soczynska; Giulia I Perini; Roger S McIntyre
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 7.  Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile.

Authors:  Brenda W J H Penninx; Yuri Milaneschi; Femke Lamers; Nicole Vogelzangs
Journal:  BMC Med       Date:  2013-05-15       Impact factor: 8.775

Review 8.  IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.

Authors:  C D Rethorst; T L Greer; M S P Toups; I Bernstein; T J Carmody; M H Trivedi
Journal:  Transl Psychiatry       Date:  2015-08-04       Impact factor: 6.222

9.  Unique cytokine signature in the plasma of patients with fibromyalgia.

Authors:  Jamie Sturgill; Elizabeth McGee; Victoria Menzies
Journal:  J Immunol Res       Date:  2014-03-11       Impact factor: 4.818

Review 10.  Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances.

Authors:  Rita Haapakoski; Klaus P Ebmeier; Harri Alenius; Mika Kivimäki
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-26       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.